Yong Lin

Active 1995–2026

445
Papers
35,198
Citations
100
h-index
366
i10-index

Citations

Citations per year for Yong Lin1979: 1 citations1991: 1 citations1993: 1 citations1995: 3 citations1996: 15 citations1997: 16 citations1998: 17 citations1999: 25 citations2000: 30 citations2001: 52 citations2002: 73 citations2003: 85 citations2004: 90 citations2005: 119 citations2006: 187 citations2007: 139 citations2008: 145 citations2009: 154 citations2010: 186 citations2011: 155 citations2012: 173 citations2013: 182 citations2014: 186 citations2015: 183 citations2016: 187 citations2017: 238 citations2018: 334 citations2019: 850 citations2020: 1,790 citations2021: 1,835 citations2022: 1,379 citations2023: 1,145 citations2024: 1,606 citations2025: 1,222 citations2026: 279 citations1980–1990: no citations, so these years are not shown1992: no citations, so this year is not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,832 citing papers, 22% of this breakdownChina: 3,323 citing papers, 19.1% of this breakdownUnited Kingdom: 830 citing papers, 4.8% of this breakdownGermany: 789 citing papers, 4.5% of this breakdownItaly: 684 citing papers, 3.9% of this breakdownIndia: 591 citing papers, 3.4% of this breakdownFrance: 484 citing papers, 2.8% of this breakdownCanada: 466 citing papers, 2.7% of this breakdownAustralia: 420 citing papers, 2.4% of this breakdownSouth Korea: 416 citing papers, 2.4% of this breakdownJapan: 412 citing papers, 2.4% of this breakdownSpain: 393 citing papers, 2.2% of this breakdown
0%22%Other 27.4%

Fields

  • Medicine44.7%
  • Biochemistry, Genetics and Molecular Biology23.4%
  • Computer Science10.2%
  • Engineering4.6%
  • Immunology and Microbiology3.7%
  • Neuroscience2.3%
  • Other11.1%

Topics

  • SARS-CoV-2 and COVID-19 Research3.7%
  • COVID-19 Clinical Research Studies3%
  • SARS-CoV-2 detection and testing2%
  • Advanced Breast Cancer Therapies1.7%
  • Cancer-related Molecular Pathways1.3%
  • Cell death mechanisms and regulation1.2%
  • Other87.1%

Coauthors

All papers

Open in search
  1. MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 1,656

  2. Active Prompting with Chain-of-Thought for Large Language Models

    Authors: , , , , , - Meeting of the Association for Computational Linguistics (Volume 1: Long Papers), ACL (1) 2024 cited by 159

  3. Mitigating the Alignment Tax of RLHF

    Authors: , , , , , , , , , , , , , , , , - Conference on Empirical Methods in Natural Language Processing, EMNLP 2024 cited by 123

  4. Goedel-Prover: A Frontier Model for Open-Source Automated Theorem Proving

    Authors: , , , , , , , , , , - ArXiv.org, CoRR 2025 cited by 103

  5. Goedel-Prover-V2: Scaling Formal Theorem Proving with Scaffolded Data Synthesis and Self-Correction

    Authors: , , , , , , , , , , , , , , , , , , , - ArXiv.org, CoRR 2025 cited by 100

  6. Inhibition of ferroptosis attenuates tissue damage and improves long‐term outcomes after traumatic brain injury in mice

    Authors: , , , , , , - CNS Neuroscience & Therapeutics 2018 cited by 394

  7. R-Tuning: Teaching Large Language Models to Refuse Unknown Questions

    Authors: , , , , , , , , - Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies (Volume 1: Long Papers), NAACL-HLT 2024 cited by 81

  8. Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

    Authors: , , , - Current Cancer Drug Targets 2008 cited by 1,163

  9. Arithmetic Control of LLMs for Diverse User Preferences: Directional Preference Alignment with Multi-Objective Rewards

    Authors: , , , , , , , - Meeting of the Association for Computational Linguistics (Volume 1: Long Papers), ACL (1) 2024 cited by 78

  10. Regularizing Hidden States Enables Learning Generalizable Reward Model for LLMs

    Authors: , , , , - Advances in Neural Information Processing Systems 37, NeurIPS 2024 cited by 149

  11. Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2022 cited by 243

  12. Tumor necrosis factor and cancer, buddies or foes?

    Authors: , - Acta Pharmacologica Sinica 2008 cited by 731

  13. Ultra-Processed Foods and Incident Cardiovascular Disease in the Framingham Offspring Study

    Authors: , , , , - Journal of the American College of Cardiology 2021 cited by 221

  14. Entropy-Regularized Process Reward Model

    Authors: , , , , , , , , - Trans. Mach. Learn. Res. 2025 cited by 38

  15. Rethinking Mixture-of-Agents: Is Mixing Different Large Language Models Beneficial?

    Authors: , , , - Trans. Mach. Learn. Res. 2026 cited by 37

  16. Antibody responses to SARS-CoV-2 in patients with COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manman Zhu, Jing Wang, Cheng-Jun Xue, Xiao-Feng Li, Li Wang, Zhi-Jie Li, Kun Wang, Chang-Chun Niu, Qing-Jun Yang, Xiao-Jun Tang, Yong Zhang, Xia-Mao Liu, Jin-Jing Li, De-Chun Zhang, Fan Zhang, Ping Liu, Jun Yuan, Qin Li, Jieli Hu, Juan Chen, Ailong Huang - Nature Medicine 2020 cited by 3,117

  17. Black-Box Prompt Learning for Pre-trained Language Models

    Authors: , , , , , , - Trans. Mach. Learn. Res. 2023 cited by 64

  18. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 166

  19. ZeroGen+: Self-Guided High-Quality Data Generation in Efficient Zero-Shot Learning

    Authors: , , , , , , , , , - ICLR 2023 cited by 64

  20. DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis

    Authors: , , , , , , , , , , , , , - Theranostics 2020 cited by 121

  21. Localize-and-Stitch: Efficient Model Merging via Sparse Task Arithmetic

    Authors: , , , , - Trans. Mach. Learn. Res. 2025 cited by 27

  22. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization

    Authors: , , , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2022 cited by 99

  23. The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes

    Authors: , , , , , , , - Cell Discovery 2021 cited by 244

  24. Ricci curvature of graphs

    Authors: , , - Tohoku Mathematical Journal 2011 cited by 250